title: Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes.
abstract: We previously discovered that insulin stimulates the marked translocation of a novel membrane aminopeptidase, designated vp165 for vesicle protein of 165 kDa, to the cell surface in adipocytes. To examine the hypothesis that this enzyme acts on peptide hormones, we assessed the relative affinity of the enzyme for 22 peptide hormones by measuring the inhibitory effect of each on the hydrolysis of a fluorogenic substrate, and we directly assayed the cleavage of four of these. Angiotensin III, angiotensin IV, and Lys-bradykinin bound to the enzyme with half-saturation constants between 20 and 600 nM and were cleaved by vp165. Vasopressin bound with lower affinity but at saturation was cleaved more rapidly. Subsequently, the effect of insulin on the rates of cleavage of 125I-labeled vasopressin by intact 3T3-L1 and rat adipocytes was determined. With both cell types, vasopressin cleavage was stimulated approximately threefold. These findings indicate that a physiological role for vp165 may be the processing of peptide hormones and that insulin could enhance the cleavage of extracellular substrates by eliciting the translocation of vp165 to the cell surface.
authors.affiliation: Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.
authors.forename: J J
authors.initials: JJ
authors.lastname: Herbst
authors.forename: S A
authors.initials: SA
authors.lastname: Ross
authors.forename: H M
authors.initials: HM
authors.lastname: Scott
authors.forename: S A
authors.initials: SA
authors.lastname: Bobin
authors.forename: N J
authors.initials: NJ
authors.lastname: Morris
authors.forename: G E
authors.initials: GE
authors.lastname: Lienhard
authors.forename: S R
authors.initials: SR
authors.lastname: Keller
mesh_terms: D016475:3T3 Cells / Q000187:drug effects / Q000378:metabolism; D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism*; D000626:Aminopeptidases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000804:Angiotensin II / Q000031:analogs & derivatives / Q000378:metabolism; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D010122:Cystinyl Aminopeptidase; D006868:Hydrolysis; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D051379:Mice; D051381:Rats; D017207:Rats, Sprague-Dawley; D013379:Substrate Specificity; D014667:Vasopressins / Q000378:metabolism*
chemical_list: D007328:Insulin; D014667:Vasopressins; D000804:Angiotensin II; C012877:angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-; D000626:Aminopeptidases; D010122:Cystinyl Aminopeptidase; C105964:leucyl-cystinyl aminopeptidase